CollPlant Biotechnologies Ltd.
CLGN
$0.42
$0.013.38%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -95.30% | -93.94% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -95.30% | -93.94% | |
| Cost of Revenue | -- | -- | -18.38% | 66.09% | |
| Gross Profit | -- | -- | -112.38% | -115.64% | |
| SG&A Expenses | -- | -- | -6.17% | -11.69% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | -3.82% | 6.49% | |
| Operating Income | -- | -- | -129.65% | -157.65% | |
| Income Before Tax | -- | -- | -136.63% | -158.80% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -136.63% | -158.80% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -136.63% | -158.80% | |
| EBIT | -- | -- | -129.65% | -157.65% | |
| EBITDA | -- | -- | -152.93% | -187.37% | |
| EPS Basic | -- | -- | -135.90% | -153.82% | |
| Normalized Basic EPS | -- | -- | -824.63% | -787.82% | |
| EPS Diluted | -- | -- | -129.48% | -146.74% | |
| Normalized Diluted EPS | -- | -- | -984.37% | -914.77% | |
| Average Basic Shares Outstanding | -- | -- | 0.62% | 1.23% | |
| Average Diluted Shares Outstanding | -- | -- | -0.28% | 0.33% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |